Robert Michael Poole - 09 Jul 2021 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Danielle Mann for Robert Michael Poole by PoA
Issuer symbol
OVID
Transactions as of
09 Jul 2021
Net transactions value
$0
Form type
4
Filing time
13 Jul 2021, 16:25:15 UTC
Next filing
04 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 09 Jul 2021 Common Stock 30,000 $3.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest as follows: 1/36th of the shares subject to the option shall vest every month after July 9, 2021, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2017 Equity Incentive Plan) on each vesting date.